TWO SIGMA ADVISERS, LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 134 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 5.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$47,168
-89.9%
35,200
-86.5%
0.00%
-100.0%
Q2 2023$465,758
-70.2%
260,200
-35.2%
0.00%
-75.0%
Q1 2023$1,561,835
-34.7%
401,500
-42.9%
0.00%
-42.9%
Q4 2022$2,390,880
-47.3%
703,200
-15.4%
0.01%
-46.2%
Q3 2022$4,539,000
+2.1%
831,300
-15.7%
0.01%0.0%
Q2 2022$4,447,000
-22.2%
986,000
+27.2%
0.01%
-13.3%
Q1 2022$5,714,000
+107.9%
775,300
+81.3%
0.02%
+114.3%
Q4 2021$2,749,000
-56.3%
427,600
-60.5%
0.01%
-56.2%
Q3 2021$6,297,000
-37.9%
1,082,000
+10.1%
0.02%
-40.7%
Q2 2021$10,138,000
+5.9%
982,400
+7.9%
0.03%
+3.8%
Q1 2021$9,575,000
+22.0%
910,200
+79.6%
0.03%
+23.8%
Q4 2020$7,847,000
-54.7%
506,900
-57.3%
0.02%
-57.1%
Q3 2020$17,314,000
+1.2%
1,185,900
+31.3%
0.05%
-2.0%
Q2 2020$17,112,000
+21.7%
903,500
+23.4%
0.05%
-7.4%
Q1 2020$14,064,000
+40.0%
732,100
+39.7%
0.05%
+134.8%
Q4 2019$10,049,000
+413.2%
524,200
+157.6%
0.02%
+360.0%
Q3 2019$1,958,000
+10.3%
203,500
-31.3%
0.01%
+25.0%
Q2 2019$1,775,000
-18.0%
296,300
-20.0%
0.00%
-20.0%
Q1 2019$2,164,000
-1.1%
370,600
+58.7%
0.01%
-16.7%
Q4 2018$2,188,000
-46.1%
233,500
-2.1%
0.01%
-40.0%
Q3 2018$4,060,000
+52.7%
238,400
+52.3%
0.01%
+42.9%
Q2 2018$2,659,000156,5000.01%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,773,474$2,376,4561.12%
AlphaCentric Advisors LLC 1,125,000$1,507,5000.86%
Tejara Capital Ltd 1,077,388$1,443,7000.82%
Palo Alto Investors LP 5,675,876$7,605,6740.72%
Birchview Capital, LP 571,832$766,2550.65%
Altium Capital Management LP 740,000$991,6000.52%
Avidity Partners Management LP 8,298,570$11,120,0840.45%
Worth Venture Partners, LLC 445,981$597,6150.36%
SILVERARC CAPITAL MANAGEMENT, LLC 561,955$753,0200.23%
DAFNA Capital Management LLC 192,678$258,1890.08%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders